Get started
Author

Jaime Espinós

Observed names: J Espinos, J Espinós, J Espinós, J. Espinos, J. Espinós, Jaime Espinos
Observed institutions: Mayo Clinic, Complejo Hospitalario de Navarra, Navarre Institute of Health Research, Hospital Clínic de Barcelona, Children's Hospital of Pittsburgh, Clinica Universidad de Navarra, Universitat de Barcelona, Universidad de Navarra
ORCID: 0000-0001-6284-7184
Observed ORCID: 0000-0001-6284-7184
OpenAlex ID: A5071073147
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
2017 · Susana Inogés, Sonia Tejada, et al. · Journal of Translational Medicine · 141
PDF
Pregnancy associated breast cancer
2008 · M. García-Manero, M.P. Royo, et al. · European Journal of Surgical Oncology · 68
Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma
2008 · M. González-Cao, S. Viteri, et al. · Oncology · 51
A new rapid desensitization protocol for chemotherapy agents.
2011 · G Gastaminza, J M de la Borbolla, et al. · PubMed · 50
Idiopathic hyperammonemia following high-dose chemotherapy
2006 · J Espinós, J Rifón, et al. · Bone Marrow Transplantation · 19
MYH polyposis syndrome: clinical findings, genetics issues and management
2014 · M. Sereno, M. Merino, et al. · Clinical & Translational Oncology · 16
Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model‐based characterization approach
2019 · Belén P. Solans, Ascensión López‐Díaz de Cerio, et al. · British Journal of Clinical Pharmacology · 14
Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer
2023 · Luisa Sánchez-Lorenzo, Alejandra Bachiller, et al. · Seminars in Oncology Nursing · 13
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
2020 · María Jesús Rubio, María José Lecumberri, et al. · Gynecologic Oncology Reports · 13
PDF
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study
2013 · Juan P. Fusco, Eduardo Castañón, et al. · Journal of Neuro-Oncology · 12
[Von Willebrand factor as an intermediate between hemostasis and angiogenesis of tumor origin].
2003 · I Gil-Bazo, V Catalán, et al. · PubMed · 12
Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience
2017 · Patricia Martin-Romano, Iosune Baraibar, et al. · The Breast Journal · 11
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.
1996 · J M Sanchez-Tapias, X Forns, et al. · Gut · 10
PDF
A Phase II Trial of Less Than 7 Weeks of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer
2010 · Rafael Martínez-Monge, Miren Gaztañaga, et al. · International Journal of Gynecological Cancer · 9
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
2023 · Luis Mejías Sosa, Álvaro López-Janeiro, et al. · Biomedicines · 8
PDF
Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: a case report
2010 · Joaquim Bosch-Barrera, Jaime Espinós · International Archives of Medicine · 6
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
2009 · Yago Nieto, José Manuel Aramendía, et al. · Cancer Chemotherapy and Pharmacology · 6
European perspective on surgical approach in early cervical cancer after LACC trial. An international ESGO survey
2019 · L. Chiva, E. Chacon, et al. · International Journal of Gynecological Cancer · 4
Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer
2016 · María Isabel Martinez-Fernandez, Jairo Legaspi Folgueira, et al. · International Journal of Gynecological Cancer · 4
Is There Any Reason to Delay Introduction of Tumor Necrosis Factor in the Management of In-Transit Metastasis of Unresectable Melanoma?
2007 · Ignacio Garrido-Laguna, Mariano Ponz, et al. · Journal of Clinical Oncology · 4
Hormonal Therapy for Breast Cancer
2005 · J Espinós, C Reyna, et al. · CA A Cancer Journal for Clinicians · 4
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line
2024 · Jaime Espinós, José Manuel Aramendía, et al. · Clinical & Translational Oncology · 3
Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
2016 · Pablo Sala Elarre, Luis Daniel Mejias, et al. · Journal of Clinical Oncology · 3
VEGF serum levels during bevacizumab plus paclitaxel combination in metastatic melanoma
2007 · S. Viteri, A. Diaz-Lagares, et al. · Journal of Clinical Oncology · 3
Immune Checkpoint Inhibitors for the Therapy of Thymoma
2020 · Alicia Quilez, Edgar F. Guillen, et al. · JTO Clinical and Research Reports · 2
Works count: 61
Citation count: 502
H-index: 11
I10-index: 13
Year
Topic
Type